Structure Therapeutics Inc. Dividends, Common Stock
Structure Therapeutics Inc. (GPCR) reported Dividends, Common Stock of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:DividendsCommonStock · last filed 2026-08-06
- Structure Therapeutics Inc. dividends, common stock for the quarter ending 2026-06-30 was $0.00.
- Structure Therapeutics Inc. dividends, common stock for the quarter ending 2026-03-31 was $0.00.
- Structure Therapeutics Inc. dividends, common stock for the quarter ending 2025-12-31 was $0.00.
- Structure Therapeutics Inc. dividends, common stock for the quarter ending 2025-09-30 was $0.00.
| Period end | Dividends, Common Stock 3 month | Dividends, Common Stock 6 month | Dividends, Common Stock 9 month | Dividends, Common Stock 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 derived: sum of 3 quarters · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 derived: sum of 3 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-17 | $0.00 derived: sum of 2 quarters · filed 2023-11-17 | $0.00 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-11-17 | $0.00 10-Q/A · filed 2023-11-17 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $0.00 10-Q/A · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |